本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Castle Biosciences, Inc.

18.91
+0.37002.00%
盘后18.910.00000.00%16:04 EDT
成交量:33.55万
成交额:629.48万
市值:5.46亿
市盈率:-102.51
高:19.06
开:18.51
低:17.89
收:18.54
数据加载中...
2019/07/23

SEC问询函

[Cover]Correspondence
2019/07/19

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/07/19

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/07/15

[修订]招股说明书

[Amend] General form for registration of securities under the Securities Act of 1933
2019/06/26

招股说明书

General form for registration of securities under the Securities Act of 1933
2007/08/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2007/07/10

交易所摘牌声明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2007/05/14

季度报告

Quarterly report [Sections 13 or 15(d)]
2007/05/14

重要事件披露

Current report, items 2.02 and 9.01
2007/05/11

持股变动声明

Statement of changes in beneficial ownership of securities
2007/04/30

企业合并公告

Prospectuses and communications, business combinations
2007/04/30

重要事件披露

Current report, items 1.01 and 9.01
2007/04/30

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2007/04/19

持股变动声明

Statement of changes in beneficial ownership of securities
2007/03/30

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2007/02/20

重要事件披露

Current report, items 2.02 and 9.01
2007/01/23

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2006/12/19

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2006/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2006/11/13

季度报告

Quarterly report [Sections 13 or 15(d)]